Yasser Ged, MBBS

Financial relationships

  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Aptitude Health
    Topic:
    honoraria
    Date added:
    10/08/2026
    Date updated:
    10/08/2026
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    MJH Life Sciences
    Topic:
    honoraria
    Date added:
    10/08/2026
    Date updated:
    10/08/2026
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Matrix Medical Communications
    Topic:
    honoraria
    Date added:
    10/08/2026
    Date updated:
    10/08/2026
  • Attribution:
    Self
    Type of financial relationship:
    Consulting Fee
    Ineligible company:
    Aveo
    Date added:
    10/08/2026
    Date updated:
    10/08/2026
  • Attribution:
    Self
    Type of financial relationship:
    Consulting Fee
    Ineligible company:
    Abbvie
    Date added:
    10/08/2026
    Date updated:
    10/08/2026
  • Attribution:
    Self
    Type of financial relationship:
    Consulting Fee
    Ineligible company:
    BostonGene
    Date added:
    10/08/2026
    Date updated:
    10/08/2026
  • Attribution:
    Self
    Type of financial relationship:
    Consulting Fee
    Ineligible company:
    Eisai
    Date added:
    10/08/2026
    Date updated:
    10/08/2026
  • Attribution:
    Self
    Type of financial relationship:
    Consulting Fee
    Ineligible company:
    Exelixis
    Date added:
    10/08/2026
    Date updated:
    10/08/2026
  • Attribution:
    Self
    Type of financial relationship:
    Consulting Fee
    Ineligible company:
    Kura Oncology
    Date added:
    10/08/2026
    Date updated:
    10/08/2026
  • Attribution:
    Self
    Type of financial relationship:
    Consulting Fee
    Ineligible company:
    Merck
    Date added:
    10/08/2026
    Date updated:
    10/08/2026

Pages

Return to Oct. 9, 2026 - 5th Annual GU Cancer Symposium - Advances in Kidney Cancer